Donaldson Capital Management’s Amgen AMGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$2.93M Sell
8,320
-118
-1% -$42.1K 0.09% 91
2025
Q4
$2.76M Sell
8,438
-14
-0.2% -$4.44K 0.09% 96
2025
Q3
$2.39M Sell
8,452
-61
-0.7% -$17.7K 0.08% 98
2025
Q2
$2.38M Sell
8,513
-199
-2% -$56.4K 0.09% 96
2025
Q1
$2.71M Sell
8,712
-676
-7% -$200K 0.1% 93
2024
Q4
$2.45M Sell
9,388
-108
-1% -$32K 0.09% 94
2024
Q3
$3.06M Sell
9,496
-795
-8% -$260K 0.12% 81
2024
Q2
$3.22M Buy
10,291
+1
+0% +$294 0.13% 74
2024
Q1
$2.93M Sell
10,290
-767
-7% -$224K 0.12% 79
2023
Q4
$3.18M Sell
11,057
-4,670
-30% -$1.27M 0.14% 72
2023
Q3
$4.23M Sell
15,727
-276
-2% -$68.9K 0.2% 59
2023
Q2
$3.55M Sell
16,003
-387
-2% -$89.8K 0.16% 70
2023
Q1
$3.96M Sell
16,390
-199
-1% -$48.8K 0.19% 67
2022
Q4
$4.36M Sell
16,589
-295
-2% -$79.1K 0.21% 61
2022
Q3
$3.81M Sell
16,884
-120
-0.7% -$29.1K 0.21% 61
2022
Q2
$4.14M Sell
17,004
-85
-0.5% -$20.8K 0.21% 60
2022
Q1
$4.13M Sell
17,089
-412
-2% -$94.7K 0.19% 66
2021
Q4
$3.94M Sell
17,501
-267
-2% -$56.4K 0.17% 69
2021
Q3
$3.78M Sell
17,768
-678
-4% -$156K 0.19% 70
2021
Q2
$4.5M Sell
18,446
-999
-5% -$246K 0.23% 67
2021
Q1
$4.84M Buy
19,445
+199
+1% +$47.5K 0.27% 59
2020
Q4
$4.42M Sell
19,246
-338
-2% -$77.9K 0.26% 61
2020
Q3
$4.98M Sell
19,584
-33
-0.2% -$8.18K 0.34% 54
2020
Q2
$4.63M Sell
19,617
-398
-2% -$90.8K 0.34% 51
2020
Q1
$4.06M Buy
20,015
+2,224
+13% +$486K 0.35% 49
2019
Q4
$4.29M Sell
17,791
-309
-2% -$68.1K 0.29% 56
2019
Q3
$3.5M Sell
18,100
-153
-0.8% -$29.4K 0.26% 56
2019
Q2
$3.36M Sell
18,253
-164,462
-90% -$29.4M 0.28% 51
2019
Q1
$34.7M Buy
182,715
+5,964
+3% +$1.14M 3.09% 7
2018
Q4
$34.4M Buy
176,751
+4,160
+2% +$812K 3.51% 5
2018
Q3
$35.8M Buy
172,591
+5,485
+3% +$1.08M 3.12% 8
2018
Q2
$30.8M Sell
167,106
-2,519
-1% -$446K 3.01% 10
2018
Q1
$28.9M Buy
169,625
+4,054
+2% +$744K 2.84% 13
2017
Q4
$28.8M Sell
165,571
-964
-0.6% -$171K 2.81% 13
2017
Q3
$31.1M Buy
166,535
+9,761
+6% +$1.73M 3.26% 7
2017
Q2
$27M Buy
156,774
+2,827
+2% +$460K 3.06% 10
2017
Q1
$25.3M Buy
153,947
+29,981
+24% +$4.98M 2.93% 14
2016
Q4
$18.1M Sell
123,966
-15,220
-11% -$2.29M 2.23% 22
2016
Q3
$23.2M Buy
139,186
+15,776
+13% +$2.67M 3.07% 12
2016
Q2
$18.8M Buy
123,410
+5,891
+5% +$916K 2.6% 20
2016
Q1
$17.6M Buy
117,519
+21,806
+23% +$3.24M 2.54% 25
2015
Q4
$15.5M Buy
95,713
+6,746
+8% +$1.06M 2.27% 26
2015
Q3
$12.3M Buy
88,967
+6,734
+8% +$1.06M 1.84% 29
2015
Q2
$12.6M Buy
+82,233
New +$13.2M 1.8% 29

Other funds holding AMGN

Donaldson Capital Management's AMGN Position: Q1 2026 in Review

Donaldson Capital Management reduced its Amgen (AMGN) stake by 1.4% in Q1 2026, selling an estimated $42.1K and leaving 8,320 shares worth $2.93M. The position accounts for 0.09% of the portfolio, ranked #91.

Donaldson Capital Management first reported a position in AMGN in Q2 2015 and has held it in 44 quarters since. The position peaked at $35.8M in Q3 2018. 3,130 funds tracked by Wall St. Rank hold AMGN as of Q1 2026.

  • Donaldson Capital Management held 8,320 shares of Amgen worth $2.93M as of Q1 2026.
  • Donaldson Capital Management sold 118 Amgen shares in Q1 2026, an estimated $42.1K.
  • Amgen made up 0.09% of Donaldson Capital Management's portfolio in Q1 2026, its #91 holding.
  • Donaldson Capital Management first reported a position in Amgen in Q2 2015 and has held it in 44 quarters since.
  • Donaldson Capital Management's Amgen position peaked at $35.8M in Q3 2018.
  • 3,130 funds tracked by Wall St. Rank held Amgen as of Q1 2026.

Based on Donaldson Capital Management's 13F filing for Q1 2026, filed 30 Apr 2026.